Best TWAS P=6.93e-11 · Best GWAS P=1e-09 conditioned to 0.948
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Adipose Subcutaneous | CYP17A1-AS1 | 0.05 | 0.02 | enet | 10 | 0.03 | 2.8e-03 | 3.5 | 5.3 | 1.1e-07 | 0.65 | 0.10 | 0.72 | FALSE |
2 | GTEx | Artery Tibial | NT5C2 | 0.06 | 0.04 | lasso | 9 | 0.02 | 1.5e-02 | 6.0 | -6.0 | 1.7e-09 | -0.92 | 0.02 | 0.94 | FALSE |
3 | GTEx | Artery Tibial | CYP17A1-AS1 | 0.08 | 0.08 | lasso | 8 | 0.06 | 2.8e-05 | 6.0 | 5.9 | 3.2e-09 | 0.89 | 0.02 | 0.98 | FALSE |
4 | GTEx | Brain Cerebellum | ARL3 | 0.20 | 0.09 | enet | 32 | 0.07 | 3.7e-03 | 5.7 | 5.8 | 8.0e-09 | 0.61 | 0.08 | 0.83 | FALSE |
5 | GTEx | Brain Cerebellum | TRIM8 | 0.34 | -0.01 | enet | 25 | 0.07 | 4.7e-03 | -2.4 | -5.5 | 3.0e-08 | -0.41 | 0.06 | 0.42 | FALSE |
6 | GTEx | Brain Cortex | CYP17A1-AS1 | 0.15 | 0.13 | lasso | 7 | 0.14 | 1.3e-04 | 5.7 | 5.4 | 7.5e-08 | 0.79 | 0.05 | 0.84 | FALSE |
7 | GTEx | Brain Nucleus accumbens basal ganglia | CYP17A1-AS1 | 0.39 | 0.22 | lasso | 3 | 0.19 | 8.2e-06 | 5.5 | 5.4 | 6.5e-08 | 0.78 | 0.09 | 0.64 | FALSE |
8 | GTEx | Breast Mammary Tissue (Female) | CYP17A1-AS1 | 0.14 | 0.01 | lasso | 11 | 0.00 | 4.7e-01 | 4.7 | 5.6 | 1.8e-08 | 0.64 | 0.04 | 0.45 | FALSE |
9 | GTEx | Lung | CYP17A1-AS1 | 0.06 | 0.08 | lasso | 3 | 0.06 | 1.6e-05 | 5.5 | 5.4 | 5.2e-08 | 0.78 | 0.10 | 0.88 | FALSE |
10 | GTEx | Nerve Tibial | CYP17A1-AS1 | 0.14 | 0.08 | lasso | 6 | 0.06 | 7.2e-05 | 5.5 | 5.6 | 1.8e-08 | 0.77 | 0.11 | 0.83 | FALSE |
11 | ROSMAP | Brain Pre-frontal Cortex | CYP17A1-AS1 | 0.15 | 0.18 | lasso | 6 | 0.19 | 1.3e-23 | 5.7 | 5.9 | 4.5e-09 | 0.77 | 0.13 | 0.86 | FALSE |
12 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | AS3MT | 0.06 | 0.09 | enet | 6 | 0.07 | 1.3e-06 | 6.1 | -6.5 | 6.9e-11 | -0.94 | 0.01 | 0.99 | TRUE |
13 | The Cancer Genome Atlas | Breast Invasive Carcinoma | AS3MT | 0.05 | 0.05 | enet | 10 | 0.05 | 4.7e-11 | 6.1 | -5.2 | 1.8e-07 | -0.94 | 0.01 | 0.99 | FALSE |
14 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | AS3MT | 0.04 | 0.05 | enet | 3 | 0.04 | 8.6e-06 | 6.1 | -6.1 | 1.1e-09 | -1.00 | 0.01 | 0.99 | FALSE |
15 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | AS3MT | 0.13 | 0.14 | blup | 62 | 0.13 | 5.6e-06 | 6.0 | -5.4 | 7.1e-08 | -0.93 | 0.02 | 0.98 | FALSE |
16 | The Cancer Genome Atlas | Rectum Adenocarcinoma | C10orf32 | 0.17 | 0.14 | blup | 52 | 0.14 | 3.2e-04 | 6.0 | -5.8 | 5.4e-09 | -0.94 | 0.02 | 0.81 | FALSE |
17 | The Cancer Genome Atlas | Thyroid Carcinoma | AS3MT | 0.23 | 0.18 | lasso | 3 | 0.18 | 1.8e-17 | 6.1 | -5.9 | 4.5e-09 | -1.00 | 0.01 | 0.99 | FALSE |
18 | The Cancer Genome Atlas | Thyroid Carcinoma | C10orf26 | 0.06 | 0.05 | lasso | 5 | 0.04 | 4.1e-05 | 5.7 | -5.6 | 2.8e-08 | -0.68 | 0.06 | 0.91 | FALSE |
19 | The Cancer Genome Atlas | Thyroid Carcinoma | CYP17A1 | 0.04 | 0.02 | lasso | 1 | 0.02 | 3.9e-03 | 6.1 | -6.1 | 1.1e-09 | -0.85 | 0.01 | 0.88 | FALSE |